BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
5.25 / 10
Netural
Liquidity flow is robust with a score of 7.38/10, reflecting positive fund inflow characteristics despite a negative overall trend in block and large-size flows. Analyst sentiment is overwhelmingly bullish, with 66.7% Strong Buy and 33.3% Buy ratings, suggesting confidence in the stock's long-term potential.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-24
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate40.0%
Is money flowing into or out of BNTC?
- BNTC holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.25/10 (Netural).
